A panel of advisers from the US Centers for Disease Control and Prevention (CDC) recommended this Thursday to administer booster doses of COVID-19 vaccines from Moderna and Johnson & Johnson (Janssen) for some cases.
The 15 members of the advisory panel voted unanimously in favor of the two recommendations.
In the case of Johnson & Johnson, experts advised a booster dose at least two months after the first for everyone who received this vaccine.
In Moderna’s, they equated their recommendation to the one approved a month ago for Pfizer, the other vaccine with messenger RNA technology, of an additional dose for those over 65 or people with immunosuppressive diseases six months after the second.
On the possibility of mixing vaccines, something that has been talked about for weeks, experts recommended without a vote that Americans receive the same serum for their booster dose as the one they were initially administered.
With the green light from the scientific committee, only the signature of the director of the CDC, Rochelle Walensky, is missing so that Americans can start receiving booster doses of Moderna or Johnson & Johnson starting this weekend.
The experts also remarked that, despite the recommendation of booster doses, all those individuals with the full regimen are still considered vaccinated.